Catalent Executives Invited to Speak on Patient Perceptions and Alternative Clinical Trial Supply Models at Upcoming ISPE Annual Conference

Share Article

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health products and global clinical supply services, today announced that Ms. Esther Sadler-Williams, Global Director, Strategic Development and Innovation, and Dr. Paul Ingram, Global Director, Clinical Supply Services, have been invited to speak at the upcoming ISPE Europe Annual Conference, to be held at the Campus Westend, Goethe-Universität, Frankfurt, Germany, on March 7th – 9th, 2016.

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health products and global clinical supply services, today announced that Ms. Esther Sadler-Williams, Global Director, Strategic Development and Innovation, and Dr. Paul Ingram, Global Director, Clinical Supply Services, have been invited to speak at the upcoming ISPE Europe Annual Conference, to be held at the Campus Westend, Goethe-Universität, Frankfurt, Germany, on March 7th – 9th, 2016.

Ms. Sadler-Williams’ presentation, on Tuesday March 8th, at 2:00 p.m., is entitled “Patient Perceptions of Investigational Medicinal Products”. She will speak as a representative of the Investigational Products Community of Practice Steering Committee, and discuss the findings from the cross-industry group’s patient survey, undertaken with a range of subjects associated with IMP (Investigational Medicinal Product) trials. The presentation will outline key findings including overall patient experience, patient perceptions around labelling and kit design, transport and storage of medicines, as well as behavior associated with returning unused medicines.

Dr. Ingram is to present “New Supply Chain Concepts and Innovations: Demand Led Supplies” on Wednesday March 9th, at 9:10 a.m., and will discuss the evolution of clinical supply models, examining how challenges within traditional models are driving change within the industry. He will give an overview of the Demand Led Supply (DLS) model, and how it impacts patients, clinical sites, clinical personnel and study sponsors, and the advantages of using a DLS model when appropriate versus traditional supply-led approaches.

Ms. Sadler-Williams M.Sc., MRPharmS, is the past EU chair of the ISPE Investigational Products Community of Practice committee. As a pharmacist, she has had nearly 30 years’ experience in various pharmaceutical fields, latterly in clinical supply environments, but she also worked for five years with Sanofi Winthrop, where she was Head of Research Services, managing groups of clinical research associates, medical writers and information/adverse event surveillance specialists. Her previous roles include Principal Pharmacist with the Regional Drug Information Service at St Mary’s Hospital in Manchester, UK, and Pharmacy Manager with Boots the Chemist.

Dr. Ingram’s 25 year career has focused on Medical Device and Pharmaceutical Research and Development. He obtained his Ph.D. in Pharmaceutical Development from Strathclyde University, Scotland, and has over 15 years of experience in clinical supplies, working both in phase I units and trial supplies service companies including Quintiles (Aptuit), Fisher Clinical and Catalent.

For more information on the 2016 ISPE Europe Annual Conference, visit: http://www.ispe.org/2016-Europe-Annual-Conference and to arrange a meeting with attending Catalent executives at the event, contact Richard Kerns at NEPR- richard(at)nepr(dot)eu.

About Catalent

Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health and global clinical supply services. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 8,700 people, including over 1,000 scientists, at 31 facilities across 5 continents, and in fiscal 2015 generated more than $1.8 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Chris Halling

Richard Kerns
Northern Exposure PR
+44 7974 579202
Email >
Visit website